BioNTech SE (NasdaqGS:BNTX) announces a share repurchase program. Under the program, the company will repurchase up to $500 million worth of its American depositary shares (ADSs). The company expects to use all or a portion of the ADSs to satisfy upcoming settlement obligations under the company's share-based payment arrangements.

The program will run for a six-month period up to November 2, 2023.